表紙
市場調査レポート

Neos Therapeutics, Inc.の製品パイプライン分析

Neos Therapeutics, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 317369
出版日 ページ情報 英文 30 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
Neos Therapeutics, Inc.の製品パイプライン分析 Neos Therapeutics, Inc. - Product Pipeline Review - 2015
出版日: 2015年07月22日 ページ情報: 英文 30 Pages
概要

Neos Therapeutics, Inc.は米国に本社をおく経口ドラッグデリバリー企業で、放出制御型の口腔内崩壊錠や液体薬などのドラッグデリバリー製品、受託製造サービスを処方薬市場およびコンシューマーヘルスケア市場に向け提供しています。

当レポートでは、Neos Therapeutics, Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Neos Therapeutics, Inc.の基本情報

  • Neos Therapeutics, Inc.の概要
  • 主要情報
  • 企業情報

Neos Therapeutics, Inc.:R&Dの概要

  • 主な治療範囲

Neos Therapeutics, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Neos Therapeutics, Inc.:パイプライン製品の概況

  • 後期段階にあるパイプライン製品
    • 新薬登録前段階の製品/併用療法モダリティ
    • 第3相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床試験段階の製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ
  • 開発段階が不明のパイプライン製品
    • 開発段階が不明の製品/併用療法モダリティ

Neos Therapeutics, Inc.:薬剤プロファイル

  • amfetamine XR
  • methylphenidate hydrochloride XR
  • Small Molecule for Cough and Cold
  • Small Molecule for Central Nervous System Disorders
  • Small Molecule for CNS Diseases
  • Small Molecule for Pain
  • Small Molecule for ADHD

Neos Therapeutics, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

最新のパイプライン情報

Neos Therapeutics, Inc.:本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07294CDB

Summary

Global Markets Direct's, 'Neos Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Neos Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neos Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Neos Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Neos Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Neos Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Neos Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Neos Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Neos Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Neos Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neos Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Neos Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Neos Therapeutics, Inc. Snapshot
    • Neos Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Neos Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Neos Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Neos Therapeutics, Inc. - Pipeline Products Glance
    • Neos Therapeutics, Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Filing rejected/Withdrawn Products/Combination Treatment Modalities
    • Neos Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Neos Therapeutics, Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Neos Therapeutics, Inc. - Drug Profiles
    • methylphenidate hydrochloride XR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • amfetamine XR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Cough and Cold
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for CNS Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Pain
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for ADHD
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Neos Therapeutics, Inc. - Pipeline Analysis
    • Neos Therapeutics, Inc. - Pipeline Products by Target
    • Neos Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Neos Therapeutics, Inc. - Pipeline Products by Molecule Type
    • Neos Therapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Neos Therapeutics, Inc. - Recent Pipeline Updates
  • Neos Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Neos Therapeutics, Inc., Key Information
  • Neos Therapeutics, Inc., Key Facts
  • Neos Therapeutics, Inc. - Pipeline by Indication, 2015
  • Neos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Neos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Neos Therapeutics, Inc. - Pre-Registration, 2015
  • Neos Therapeutics, Inc. - Filing rejected/Withdrawn, 2015
  • Neos Therapeutics, Inc. - Preclinical, 2015
  • Neos Therapeutics, Inc. - Discovery, 2015
  • Neos Therapeutics, Inc. - Unknown, 2015
  • Neos Therapeutics, Inc. - Pipeline by Target, 2015
  • Neos Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Neos Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Neos Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Neos Therapeutics, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Neos Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Neos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Neos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Neos Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top